Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Applied Therapeutics (APLT) Short-Term Debt repayments (2023 - 2024)

Historic Short-Term Debt repayments for Applied Therapeutics (APLT) over the last 2 years, with Q1 2024 value amounting to $311000.0.

  • Applied Therapeutics' Short-Term Debt repayments fell 5000.0% to $311000.0 in Q1 2024 from the same period last year, while for Dec 2024 it was $311000.0, marking a year-over-year decrease of 8326.16%. This contributed to the annual value of $311000.0 for FY2024, which is 8326.16% down from last year.
  • Applied Therapeutics' Short-Term Debt repayments amounted to $311000.0 in Q1 2024, which was down 5000.0% from $465000.0 recorded in Q4 2023.
  • In the past 5 years, Applied Therapeutics' Short-Term Debt repayments registered a high of $622000.0 during Q1 2023, and its lowest value of $306000.0 during Q2 2023.